![]() |
||||||||||
![]() |
||||||||||
|
UK Portfolio US Portfolio |
Proven novel ingredients for functional foods Overview In response, Provexis developed Fruitflow®, a patented bioactive extract of tomato that inhibits platelet aggregation. Within just three hours of consumption a noticeable effect is observable, reducing the risk of thrombosis which underpins heart attack and stroke. This gives Fruitflow® elite status as one of only a few products available to carry a scientifically substantiated health claim: ‘Helps maintain a healthy heart and benefit circulation.’ In an increasingly health-conscious society looking for products which are both effective and natural in origin, Provexis aims to develop further novel, patented active food components for integration into innovative functional foods and beverages. These development programmes are typically undertaken in partnership with leading academic research establishments and always aim to develop products that have a health benefit which is both clearly defined and scientifically proven. Market opportunity In addition, a number of further products are in the pipeline. These include a plantain extract which will underpin a novel medical food for the dietary management of Inflammatory Bowel Disease. Progress In the beverage sector, discussions regarding an Exclusive Agreement are underway with a global leader in beverage brands. The Company is also carrying out a product application assessment of Fruitflow® with a further global food and beverage corporation. Work continues on a potential deep vein thrombosis product. In the company year, the management team will accelerate its efforts to gain a foothold in the dietary supplement market. Website: www.provexis.com
|
|||||||||